ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,999Medicare Part D Prescriptions Filled, Including Refills

Rank: 76 out of 2035

$1.08M Total Retail Price of All Prescriptions

Rank: 33 out of 2035

641 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 641 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

22% of this provider’s 641 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 11,083 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 748 451 S3 1 2
SIMVASTATIN 452 356 2 1
FUROSEMIDE 443 400 3 7
OMEPRAZOLE 437 364 4 5
LEVOTHYROXINE SODIUM 393 336 5 4
LISINOPRIL 341 281 6 3
METFORMIN HCL 304 246 7 9
POTASSIUM CHLORIDE 283 266 8 18
AMLODIPINE BESYLATE 281 258 9 6
CARVEDILOL 268 231 10 22
METOPROLOL SUCCINATE 216 169 11 16
WARFARIN SODIUM 196 182 12 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 192 126 13 26
CLOPIDOGREL 184 160 14 30
ZOLPIDEM TARTRATE 181 129 15 21
ISOSORBIDE MONONITRATE ER 181 168 15 32
GABAPENTIN 172 91 17 14
METOPROLOL TARTRATE 165 144 18 8
AZITHROMYCIN 164 141 19 39
GLIMEPIRIDE 148 124 20 55
ATENOLOL 145 125 21 10
PRAVASTATIN SODIUM 139 121 22 17
LOSARTAN-HYDROCHLOROTHIAZIDE 133 128 23 47
PLAVIX 129 111 24 49
ATORVASTATIN CALCIUM 128 112 25 13
SERTRALINE HCL 127 91 26 23
CITALOPRAM HBR 121 105 27 20
MELOXICAM 115 79 28 56
GLYBURIDE 114 85 R 29 74
LANTUS 109 90 30 40
ZETIA 106 89 31 84
TAMSULOSIN HCL 105 96 32 25
OXYCODONE HCL-ACETAMINOPHEN 104 41 S2 33 127
ALLOPURINOL 99 95 34 34
LOSARTAN POTASSIUM 98 93 35 15
PREDNISONE 96 83 36 36
PROAIR HFA 96 68 36 31
PAROXETINE HCL 96 85 36 69
NEXIUM 92 77 39 51
HYDROCHLOROTHIAZIDE 88 85 40 12
INSULIN SYRINGE 87 67 41 97
CIPROFLOXACIN HCL 86 66 42 63
CYCLOBENZAPRINE HCL 83 40 R 43 64
GEMFIBROZIL 81 66 44 114
SULFAMETHOXAZOLE-TRIMETHOPRIM 77 57 45 110
TRAMADOL HCL 74 64 46 19
LANTUS SOLOSTAR 73 57 47 66
DILTIAZEM 24HR CD 72 59 48 122
GLIPIZIDE 72 63 48 54
RANITIDINE HCL 72 68 48 28
TORSEMIDE 71 65 51 157
MORPHINE SULFATE ER 70 11 S2 52 86
TRIAMTERENE-HYDROCHLOROTHIAZID 67 59 53 241
METHYLPREDNISOLONE 67 62 53 125
ENALAPRIL MALEATE 63 50 55 60
DIGOXIN 62 55 56 67
DOXAZOSIN MESYLATE 61 52 57 111
FINASTERIDE 61 61 57 105
TRIAMTERENE-HCTZ 60 47 59 35
SPIRIVA 58 30 60 44
RAMIPRIL 58 54 60 135
DONEPEZIL HCL 58 58 60 24
CRESTOR 57 52 63 41
BUMETANIDE 53 33 64 79
CYMBALTA 53 43 64 59
ROPINIROLE HCL 53 47 64 113
FENOFIBRATE 53 41 64 82
AMITRIPTYLINE HCL 52 28 R 68 101
HYDRALAZINE HCL 51 44 69 45
SYNTHROID 51 50 69 83
LOVASTATIN 50 50 71 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 23, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.